Benzinga | Oct 29, 2020 04:48PM EDT

ResMed Q1 Adj. EPS $1.27 Beats $0.99 Estimate, Sales $751.90M Beat $699.03M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $0.99 by 28.28 percent. This is a 36.56 percent increase over earnings of $0.93 per share from the same period last year. The company reported quarterly sales of $751.90 million which beat the analyst consensus estimate of $699.03 million by 7.56 percent. This is a 10.40 percent increase over sales of $681.06 million the same period last year.